Clinical Focus: From Mechanism to Management—Novel C5 Inhibitors in Generalized Myasthenia Gravis  

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Novel C5 Inhibitors in Generalized Myasthenia Gravis: Using Mechanism to Inform Management

Content Format:

Slideset

Credit Type:

--

Credits:

--
Mechanism Matters: The Future of Targeted Treatments in Myasthenia Gravis

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

0.50
Mechanism Matters in gMG: Why Complement and FcRn Are Reshaping Treatment Conversations

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

0.25
A Changing Treatment Paradigm of Myasthenia Gravis: A Focus on Novel Targeted Treatments

Content Format:

Slideset

Credit Type:

--

Credits:

--